Low iodine diet does not improve the efficacy of radioiodine for the treatment of Graves’ disease

Objective Consuming a low-iodine diet (LID) is a widely accepted practice before administering radioiodine (131I) to evaluate and to treat thyroid disease. Although this procedure is well established for the management of patients with differentiated thyroid cancer, its use in patients with benign disease is unclear. So, we aimed to evaluate the influence of a LID on the outcome in patients with Graves’ disease (GD) treated with131I. Subjects and methods We evaluated 67 patients with GD who were divided into 2 groups: one group (n = 31) consumed a LID for 1-2 weeks, and the second group (n = 36) was instructed to maintain a regular diet (RD). Results The LID group experienced a 23% decrease in urinary iodine after 1 week on the diet and a significant 42% decrease after 2 weeks on the diet. The majority (53%) of the patients in the LID group had urinary iodine levels that were consistent with deficient iodine intake. However, there was no difference in the rate of hyperthyroidism’s cure between the LID and the RD groups 6 months after 131I therapy. Furthermore, the therapeutic efficacy did not differ in patients with varying degrees of sufficient iodine intake (corresponding urinary iodine levels: < 10 μg/dL is deficient; 10-29.9 μg/dL is sufficient; and > 30 μg/dL is excessive). Conclusion In the present study, we demonstrated that although a LID decreased urinary iodine levels, those levels corresponding with sufficient or a mild excess in iodine intake did not compromise the therapeutic efficacy of131I for the treatment of GD.

Efeito da compressäo pneumática intermitente sequencial sobre o linfedema dos embros inferiores: avaliaçäo quantitativa pela linfocintilografia / Effect of sequential intermittent pneumatic compression (SIPC) on lymphedema of the lower extremities: quantitative evaluation by lymphoscintigraphy

Para avaliar o efeito da compressäo pneumática intermitente sequencial sobre o transporte do Dextran marcado com tecnécio 99m em pacientes com linfedema de extremidades inferiores estudamos 11 pacientes.Foram oito mulheres e três homens com idade média de 44,6 anos.Foram realizadas duas linfocintilografias: a primeira considerada o controle (sem compresäo); a segunda foi realizada com compressäo pneumática de três horas, iniciada logo após a injeçäo do radioisótopo.Antes do início da compressäo e logo após o término foram feitas medidas em seis locais marcados para verificar a efetividade da compressäo na reduçäo do volume da extremidade.A análise quantitativa foi realizada pelo cálculo do "clearance" do radioisótopo em quatro locais determinados (perna, joelho, coxa e regiäo inguinal) em ambas as linfocintilografias.Observou-se reduçäo significante entre dos diâmetros das extremidades, porém näo foi observada diferença significativa entre os valores do "clearance" sem e com compressäo.Concluímos que a compressäo pneumática intermitente sequencial foi efetiva para reduzier o diâmetro, porém näo alterou o transporte do radioisótopo nas extremidades estudadas, em três horas de compressäo.

Mapeamento radioisotópico do foco arritmogênico em portadores de cardiopatia chagásica crônica e taquicardia ventricular sustentada / Radionuclide Angiography for Localization of the Site of Origin of Sustained Ventricular Tachycardia in Chronic Chagasic Cardiomyopathy

PURPOSE--To localize the site of the origin of sustained ventricular tachycardia in chronic chagasic cardiomyopathy patients refractory to antiarrhythmic therapy by radionuclide angiography techniques. METHODS--Five patients underwent radionuclide angiography by intravenous administration of 25mCi 99mTc. The images were obtained in sinus rhythm and during sustained ventricular tachycardia induced in the electrophysiologic laboratory for endocardial mapping. Amplitude and phase images were obtained resulting in a contraction wave synchronic to ventricular dispolarization. RESULTS--All patients had haemodynamic stability during the arrhythmia. One patient had incessant ventricular tachycardia. Mean ejection fraction was 0.38. In 4 patients the site of the origin of ventricular tachycardia was posterior and in one it was localized in the interventricular septum. There was identity in the site of the origin of ventricular tachycardia obtained by endocardial mapping or radionuclide angiography in all patients. The therapy was chemical ablation in 3 patients, surgical aneurysmectomy in one and pharmacologic therapy in the last patient. CONCLUSION--The site of the origin of ventricular tachycardia can be estimated by analyzing the contraction wave obtained by radionuclide angiography techniques in patients with hemodynamic stable sustained ventricular tachycardia.